<DOC>
	<DOCNO>NCT03000712</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety intra-articular injection autologous adipose tissue derive mesenchymal stem cell compare high tibial osteotomy negative control osteoarthritis patient</brief_summary>
	<brief_title>Investigator Initiated Trial Evaluate Efficacy Safety Intra-articular Injection ADMSC Comared Negative Control After High Tibial Osteotomy Osteoarthritis Patients .</brief_title>
	<detailed_description>In clinical trial , investigational product administer intra-articularly 1 week high tibial osteotomy patient degenerative arthritis medial side . The investigational product autologous adipose-derived mesenchymal stem cell . As use allogenic tissue incubate without additional genetic modification mechanical chemical modification differentiation , classify 'autologous cell therapy ' completely free immunologic rejection . It primarily aim regenerate cartilage , improve pain joint function . The intra-articular injection investigational product expect stimulate regeneration growth cartilage , innovatively improve pain joint function cartilage regeneration compare high tibial osteotomy alone .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Patients must consent write participate study sign date informed consent document 2 . Patients communicate ( exclusion anyone understand questionnaire ) 3. 20 year 80 year age 4 . BMIâ‰¤30 5 . Diagnosis osteoarthritis radiographic criterion Kellgren Lawrence grade 24 6 . Diagnosis osteoarthritis ACR ( American College Rheumatology Criteria ) Global functional criterion : There pain knee radiographic osteophyte least one follow ( 1 ) age &gt; 50 year ( 2 ) Less 30 minute morning stiffness ( 3 ) The friction When move weight knee 7 . Patients agree contraception 8 . Patients agree stop exist osteoarthritis treatment get enough washout period medication time 9 . Patients schedule High tibial osteotomy due medial gonarthrosis 1. patient osteoporosis 2 . Preparing Pregnancy Pregnant woman lactate mother . 3 . Patients positive human immunodeficiency ( HIV ) , hepatitis B ( HBV ) , hepatitis C ( HCV ) , venereal disease research laboratory ( VDRL ) 4 . Patients hypersensitivity investigator product investigational product component history 5 . Patients participate clinical trial within 12 week prior study 6 . Patients receive drug intraarticular injection treatment within 2 month prior enrollment . 7 . Patients experience knee joint cartilage stem cell therapy failure treat 8 . Patents start change physical therapy program establish within 2 week start study study ( An establish physical therapy program may continue duration trial , provide change frequency intensity ) 9 . Patents include follow specific risk group may influence safety efficacy assessment discretion investigator : : septic arthtritis , rheumatic disease , gout , recurrent pseudogout , paget disease , joint fracture , alcaptonuria , acromegaly , hemochromatosis , wilson 's disease , primary osteochondrosis , hereditary disorder ( ex : hyperkinesia ) , collagen gene abnormality , etc 10 . Patients clinically significant severe medical illness judge principal investigator 11 . Patients diagnosed malignancy within 5 year screen ( except patient completely remissioned three year screen criterion ) 12 . Patients principal investigator consider inappropriate clinical trial due reason 13 . Patients receive concomitant contraindication pass prescribe washout period participate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>adipose tissue derive mesenchymal stem cell</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>degenerative arthritis</keyword>
	<keyword>kyung hee university hospital</keyword>
	<keyword>biostar</keyword>
	<keyword>Rbio</keyword>
	<keyword>Osteoarthritis , Knee</keyword>
	<keyword>High tibial osteotomy</keyword>
	<keyword>Joint Diseases</keyword>
</DOC>